Helicobacter hepaticus infection induces sustained inflammation and carcinoma of the liver in A/JCr mice, and serves as a model of human cancers associated with viral hepatitis and H. pylori chronic gastritis. Here we describe the pathogenesis of premalignant disease in A/JCr mice infected with H. hepaticus. We inoculated dams intragestationally and/or pups postnatally, and evaluated offspring at 3, 6, or 12 months. Mice infected at or before 3 weeks of age, but not at 12 weeks, developed disease. Male mice were most affected, but expressed a bimodal pattern of susceptibility. Males exhibited lobular necrogranulomatous and interface (chronic active) hepatitis, while females usually developed intraportal (chronic persistent) hepatitis. Portal inflammation was slowly progressive, with tertiary lymphoid nodule development by 12 months. Hepatic bacterial load and preneoplastic lesions, including clear and tigroid cell foci of cellular alteration, were correlated with lobular hepatitis severity. No extrahepatic surrogate disease marker reliably predicted individual hepatitis grade. In conclusion, gender and bacterial exposure timing are key determinants of H. hepaticus disease outcomes. Intrahepatic inflammation is driven by local signals characterized by a vigorous but nonsterilizing immune response. Continued study of chronic hepatitis progression may reveal therapeutic targets to reduce the risk of hepatocellular carcinoma.
Avenaud, P., Le Bail, B., Mayo, K., Marais, A., Fawaz, R., Bioulac-Sage, P., and Megraud, F. (2003). Natural history of Helicobacter hepaticus infection in conventional A/J mice, with special reference to liver involvement. Infect Immun71, 3667—72.
2.
Bannasch, P., Benner, U., Enzmann, H., and Hacker, H.J. (1985). Tigroid cell foci and neoplastic nodules in the liver of rats treated with a single dose of aflatoxin B1. Carcinogenesis6, 1641—8.
3.
Bannasch, P., Nehrbass, D., and Kopp-Schneider, A. (2001). Significance of hepatic preneoplasia for cancer chemoprevention. IARC Sci Publ154, 223—40.
4.
Bannasch, P., and Schroeder, C.H. (2002). 2. Tumours and tumour-like lesions of the liver and biliary tract: aetiology, epidemiology and pathology. In Pathology of the Liver (R. N. M. MacSween , A. D. Burt, B. C. Portman, K. G. Ishak, P. J. Scheuer and P. P. Anthony, eds.), pp. 777—826. Churchill Livingstone, London.
Brunt, E.M. (2000). Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology31, 241—6.
7.
Canella, K.A., Diwan, B.A., Gorelick, P.L., Donovan, P.J., Sipowicz, M.A., Kasprzak, K.S., Weghorst, C.M., Snyderwine, E.G., Davis, C.D., Keefer, L.K., Kyrtopoulos, S.A., Hecht, S.S., Wang, M., Anderson, L.M., and Rice, J.M. (1996). Liver tumorigenesis by Helicobacter hepaticus: considerations of mechanism. In Vivo10, 285—92.
8.
Diwan, B.A., Ward, J.M., Ramljak, D., and Anderson, L.M. (1997). Promotion by Helicobacter hepaticus-induced hepatitis of hepatic tumors initiated by N-nitrosodimethylamine in male A/JCr mice. Toxicol Pathol25, 597—605.
9.
Dore, M.P., Realdi, G., Mura, D., Graham, D.Y., and Sepulveda, A.R. (2002). Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig Dis Sci47, 1638—43.
10.
Erdman, S.E., Poutahidis, T., Tomczak, M., Rogers, A.B., Cormier, K., Plank, B., Horwitz, B.H., and Fox, J.G. (2003a). CD4(+) CD25(+) Regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol162, 691—702.
11.
Erdman, S.E., Rao, V.P., Poutahidis, T., Ihrig, M.M., Ge, Z., Feng, Y., Tomczak, M., Rogers, A.B., Horwitz, B.H., and Fox, J.G. (2003b). CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res63, 6042—50.
12.
Fan, X.G., Peng, X.N., Huang, Y., Yakoob, J., Wang, Z.M., and Chen, Y.P. (2002). Helicobacter species ribosomal DNA recovered from the liver tissue of chinese patients with primary hepatocellular carcinoma . Clin Infect Dis35, 1555—7.
13.
Ferrell, L.D., Theise, N.D., and Scheuer, P.J. (2002). Acute and chronic viral hepatitis. In Pathology of the Liver (R. N. M. MacSween , A. D. Burt, B. C. Portmann, K. G. Ishak, P. J. Scheuer and P. P. Anthony, eds.), pp. 313—362. Churchill Livingstone, London.
14.
Fox, J. (1998). Enterohepatic Helicobacters: natural and experimental models. Ital J Gastroenterol Hepatol30 Suppl 3, S264—9.
15.
Fox, J.G., Dewhirst, F.E., Shen, Z., Feng, Y., Taylor, N.S., Paster, B.J., Ericson, R.L., Lau, C.N., Correa, P., Araya, J.C., and Roa, I. (1998a). Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology114, 755—63.
16.
Fox, J.G., Dewhirst, F.E., Tully, J.G., Paster, B.J., Yan, L., Taylor, N.S., Collins, M.J., Jr., Gorelick, P.L., and Ward, J.M. (1994). Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice . J Clin Microbiol32, 1238—45.
17.
Fox, J.G., Li, X., Yan, L., Cahill, R.J., Hurley, R., Lewis, R., and Murphy, J.C. (1996a). Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of Helicobacter-induced carcinogenesis. Infect Immun64, 1548—58.
18.
Fox, J.G., MacGregor, J.A., Shen, Z., Li, X., Lewis, R., and Dangler, C.A. (1998b). Comparison of methods of identifying Helicobacter hepaticus in B6C3F1 mice used in a carcinogenesis bioassay. J Clin Microbiol36, 1382—7.
19.
Fox, J.G., Rogers, A.B., Ihrig, M., Taylor, N.S., Whary, M.T., Dockray, G., Varro, A., and Wang, T.C. (2003a). Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res63, 942—50.
20.
Fox, J.G., Wang, T.C., Rogers, A.B., Poutahidis, T., Ge, Z., Taylor, N., Dangler, C.A., Israel, D.A., Krishna, U., Gaus, K., and Peek, R.M., Jr. (2003b). Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia . Gastroenterology124, 1879—90.
21.
Fox, J.G., Yan, L., Shames, B., Campbell, J., Murphy, J.C., and Li, X. (1996b). Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect Immun64, 3673—81.
22.
Fukuda, K., Kuroki, T., Tajima, Y., Tsuneoka, N., Kitajima, T., Matsuzaki, S., Furui, J., and Kanematsu, T. (2002). Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis23, 1927—31.
23.
Garcia, A., Erdman, S.E., Xu, S., Feng, Y., Rogers, A.B., Schrenzel, M.D., Murphy, J.C., and Fox, J.G. (2002). Hepatobiliary inflammation, neoplasia, and argyrophilic bacteria in a ferret colony. Vet Pathol39, 173—9.
24.
Ge, Z., White, D.A., Whary, M.T., and Fox, J.G. (2001). Fluorogenic PCRbased quantitative detection of a murine pathogen, Helicobacter hepaticus. J Clin Microbiol39, 2598—602.
25.
Hailey, J.R., Haseman, J.K., Bucher, J.R., Radovsky, A.E., Malarkey, D.E., Miller, R.T., Nyska, A., and Maronpot, R.R. (1998). Impact of Helicobacter hepaticus infection in B6C3F1 mice from twelve National Toxicology Program two-year carcinogenesis studies. Toxicol Pathol26, 602—11.
26.
Haseman, J.K., Hailey, J.R., and Morris, R.W. (1998). Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program update. Toxicol Pathol26, 428—41.
27.
Iwp. (1995). Terminology of nodular hepatocellular lesions. International Working Party . Hepatology22, 983—93.
28.
Kelley, J.R., and Duggan, J.M. (2003). Gastric cancer epidemiology and risk factors. J Clin Epidemiol56, 1—9.
29.
Kew, M.C. (2002). Epidemiology of hepatocellular carcinoma. Toxicology181— 182, 35—8.
30.
Leong, R.W., and Sung, J.J. (2002). Review article: Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther16, 1037—45.
31.
Lerat, H., Honda, M., Beard, M.R., Loesch, K., Sun, J., Yang, Y., Okuda, M., Gosert, R., Xiao, S.Y., Weinman, S.A., and Lemon, S.M. (2002). Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus . Gastroenterology122, 352—65.
32.
Malarkey, D.E., Ton, T.V., Hailey, J.R., and Devereux, T.R. (1997). A PCR-RFLP method for the detection of Helicobacter hepaticus in frozen or fixed liver from B6C3F1 mice. Toxicol Pathol25, 606—12.
33.
Matsukura, N., Yokomuro, S., Yamada, S., Tajiri, T., Sundo, T., Hadama, T., Kamiya, S., Naito, Z., and Fox, J.G. (2002). Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai Patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res93, 842—7.
34.
Myles, M.H., Livingston, R.S., Livingston, B.A., Criley, J.M., and Franklin, C.L. (2003). Analysis of gene expression in ceca of Helicobacter hepaticus-infected A/JCr mice before and after development of typhlitis. Infect Immun71, 3885—93.
35.
NIH (2003). National Institutes of Health Consensus Development Conference Statement Management of Hepatitis C: 2002 June 10—12, 2002. HIV Clin Trials4, 55—75.
36.
Nilsson, H.O., Taneera, J., Castedal, M., Glatz, E., Olsson, R., and Wadstrom, T. (2000). Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol38, 1072—6.
37.
Okuda, M., Li, K., Beard, M.R., Showalter, L.A., Scholle, F., Lemon, S.M., and Weinman, S.A. (2002). Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology122, 366—75.
38.
Ponzetto, A., Pellicano, R., Leone, N., Cutufia, M.A., Turrini, F., Grigioni, W.F., D'Errico, A., Mortimer, P., Rizzetto, M., and Silengo, L. (2000). Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker?Med Hypotheses54, 275—7.
39.
Rice, J.M. (1995). Helicobacter hepaticus, a recently recognized bacterial pathogen, associated with chronic hepatitis and hepatocellular neoplasia in laboratory mice. Emerg Infect Dis1, 129—31.
40.
Rogers, A.B., and Fox, J.G. (2004). Inflammation and cancer. I. Rodent models of infectious gastrointestinal and liver cancer. Am J Physiol Gastrointest Liver Physiol286, G361—6.
41.
Rogers, A.B., Mathiason, C.K., and Hoover, E.A. (2002). Immunohistochemical localization of feline immunodeficiency virus using native species antibodies. Am J Pathol161, 1143—51.
42.
Santoni-Rugiu, E., Jensen, M.R., Factor, V.M., and Thorgeirsson, S.S. (1999). Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption. Am J Pathol154, 1693—700.
43.
Scheuer, P.J., Standish, R.A., and Dhillon, A.P. (2002). Scoring of chronic hepatitis. Clin Liver Dis6, 335—47, v—vi.
44.
Shibuya, K., Mathers, C.D., Boschi-Pinto, C., Lopez, A.D., and Murray, C.J. (2002). Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer2, 37.
45.
Shomer, N.H., Fox, J.G., Juedes, A.E., and Ruddle, N.H. (2003). Helicobacter-induced chronic active lymphoid aggregates have characteristics of tertiary lymphoid tissue. Infect Immun71, 3572—7.
46.
Solnick, J.V., and Schauer, D.B. (2001). Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin Microbiol Rev14, 59—97.
47.
Strauss, R.M., Wang, T.C., Kelsey, P.B., Compton, C.C., Ferraro, M.J., Perez-Perez, G., Parsonnet, J., and Blaser, M.J. (1990). Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Am J Med89, 464—9.
48.
Takahashi, M., Dinse, G.E., Foley, J.F., Hardisty, J.F., and Maronpot, R.R. (2002). Comparative prevalence, multiplicity, and progression of spontaneous and vinyl carbamate-induced liver lesions in five strains of male mice. Toxicol Pathol30, 599—605.
49.
Tomczak, M.F., Erdman, S.E., Poutahidis, T., Rogers, A.B., Holcombe, H., Plank, B., Fox, J.G., and Horwitz, B.H. (2003). NF-κβ is required within the innate immune system to inhibit microflora-induced colitis and expression of IL-12 p40. J Immunol171, 1484—92.
50.
Ward, J.M., Anver, M.R., Haines, D.C., and Benveniste, R.E. (1994a). Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am JPathol145, 959—68.
51.
Ward, J.M., Benveniste, R.E., Fox, C.H., Battles, J.K., Gonda, M.A., and Tully, J.G. (1996). Autoimmunity in chronic active Helicobacter hepatitis of mice. Serum antibodies and expression of heat shock protein 70 in liver . Am J Pathol148, 509—17.
52.
Ward, J.M., Fox, J.G., Anver, M.R., Haines, D.C., George, C.V., Collins, M.J., Jr., Gorelick, P.L., Nagashima, K., Gonda, M.A., Gilden, R.V., Tully, J.G., Russell, R.J., Benveniste, R.E., Paster, B.J., Dewhirst, F.E., Donovan, J.C., Anderson, L.M., and Rice, J.M. (1994b). Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst86, 1222—7.
53.
Waris, G. (2003). Regulatory mechanisms of viral hepatitis B and C. J Biosci28, 311—21.
54.
Whary, M.T., Cline, J., King, A., Ge, Z., Shen, Z., Sheppard, B., and Fox, J.G. (2001). Long-term colonization levels of Helicobacter hepaticus in the cecum of hepatitis-prone A/JCr mice are significantly lower than those in hepatitis-resistant C57BL/6 mice. Comp Med51, 413—7.
55.
Whary, M.T., Cline, J.H., King, A.E., Hewes, K.M., Chojnacky, D., Salvarrey, A., and Fox, J.G. (2000). Monitoring sentinel mice for Helicobacter hepaticus, H. rodentium, and H. bilis infection by use of polymerase chain reaction analysis and serologic testing. Comp Med50, 436—43.
56.
Whary, M.T., Morgan, T.J., Dangler, C.A., Gaudes, K.J., Taylor, N.S., and Fox, J.G. (1998). Chronic active hepatitis induced by Helicobacter hepaticus in the A/JCr mouse is associated with a Th1 cell-mediated immune response. Infect Immun66, 3142—8.
57.
Young, V.B., Knox, K.A., Pratt, J.S., Cortez, J.S., Mansfield, L.S., Rogers, A.B., Fox, J.G., and Schauer, D.B. (2004). In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect Immun72, 2521—7.
